Adenoassociated virus vectors for genetic immunization

Immunologic Research

Volumn 26, Issue 1-3, 2002, Pages 247-253

  Ponnazhagan, Selvarangan ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Adenoassociated virus; Genetic vaccination; Immunotherapy; Tumor antigens; Viral vector

Indexed keywords

ADENOVIRUS VECTOR; DNA VACCINE; TUMOR ANTIGEN; VACCINE;

ADENO ASSOCIATED VIRUS; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; GENE THERAPY; GENE TRANSFER; IMMUNITY; IMMUNIZATION; IMMUNOGENETICS; IMMUNOTHERAPY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSGENE;

ANIMALS; DEPENDOVIRUS; GENE THERAPY; GENETIC VECTORS; HUMANS; IMMUNITY, CELLULAR; IMMUNIZATION; IMMUNOTHERAPY; MUSCLE, SKELETAL; VACCINES, DNA;

EID: 0036397656     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:26:1-3:247     Document Type: Article

References (53)

1. Muzyczka N: Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr Top Microbiol Immunol 1992;158:97-129.
2. Carter PJ, Samulski RJ: Adeno-associated viral vectors as gene delivery vehicles. Int J Mol Med 2000;6:17-27.
3. Ponnazhagan S, Curiel DT, Shaw DR, Alvarez RD, Siegal GP: Adeno-associated virus for cancer gene therapy. Cancer Res 2001;61:6313-6321.
4. Snyder RO: Adeno-associated virus-mediated gene delivery. J Gene Med 1999;1:166-175.
5. Tal J: Adeno-associated virus-based vectors in gene therapy. J Biomed Sci 2000;7:279-291.
6. Halbert CL, Rutledge EA, Allen JM, Russell DW, Miller AD: Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J Virol 2000;74:1524-1532.
7. Davidson BL, Stein CS, Heth JA, Martins I, Kotin RM, Derksen TA, Zabner J, Ghodsi A, Chiorini JA: Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci USA 2000;97:3428-3432.
8. Hildinger M, Auricchio A, Gao G, Wang L, Chirmule N, Wilson JM: Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. J Virol 2001;75:6199-6203.
9. Chiorini JA, Kim F, Yang L, Kotin RM: Cloning and characterization of adeno-associated virus type 5. J Virol. 1999;73:1309-1319.
10. Xiao W, Chirmule N, Berta SC, McCullough B, Gao G,Wilson JM: Gene therapy vectors based on adeno-associated virus type 1. J Virol 1999;73:3994-4003.
11. Chiorini JA, Yang L, Liu Y, Safer B, Kotin RM: Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles. J Virol 1997;71:6823-6833.
12. Samulski RJ, Chang LS, Shenk T: Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Virol 1989;63:3822-3838.
13. Ponnazhagan S, Yoder MC, Srivastava A: Adeno-associated virus 2-mediated transduction of murine repopulating hematopoietic stem cells and long-term expression of a human globin gene in vivo. J Virol 1997;71:3098-3104.
14. Schimmenti S, Boesen J, Claassen EA, Valerio D, Einerhand MP: Long-term genetic modification of rhesus monkey hematopoietic cells following transplantation of adenoassociated virus vector-transduced CD34+ cells. Hum Gene Ther 1998;9:2727-2734.
15. Xiao W, Berta SC, Lu MM, Moscioni AD, Tazelaar J, Wilson JM: Adeno-associated virus as a vector for liver-directed gene therapy. J Virol 1998;72:10,222-10,226.
16. During MJ, Samulski RJ, Elsworth, JD, Kaplitt MG, Leone P, Xiao X, Li J, Freese A, Taylor JR, Roth RH, Sladek JR, O'Malley KL, Redmond DE: In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector. Gene Ther 1998;5:820-827.
17. Zhou S, Murphy JE, Escobedo JA, Dwarki VJ: Adeno-associated virus-mediated delivery of erythropoietin leads to sustained elevation of hematocrit in nonhuman primates. Gene Ther 1998;5:665-670.
18. Li J, Dressman D, Tsao YP, Sakamoto A, Hoffman EP, Xiao X: rAAV vector-mediated sarcoglycan gene transfer in a hamster rodent model for limb girdle muscular dystrophy. Gene Ther 1999;6:74-82.
19. Wang L, Takabe K, Bidlingmaier SM, Ill CR, Verma IM: Sustained correction of bleeding disorder in hemophilia B mice by gene therapy. Proc Natl Acad Sci USA 1999;96:3906-3910.
20. Su H, Lu R, Kan YW: Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart. Proc Natl Acad Sci USA 2000;97:13,801-13,806.
21. Flotte T, Carter B, Conrad C, Guggino W, Reynolds T, Rosenstein B, Taylor G, Walden S, Wetzel R: A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease. Hum Gene Ther 1996;7:1145-1159.
22. Wagner JA, Moran ML, Messner AH, Daifuku R, Conrad CK, Reynolds T, Guggino WB, Moss RB, Carter BJ, Wine JJ, Flotte TR, Gardner P: A phase I/II study of tgAAV-CF for the treatment of chronic sinusitis in patients with cystic fibrosis. Hum Gene Ther 1998;10:889-909.
23. Kay MA, Manno CS, Ragni MV, Larson PJ, Couto LB, McClelland A, Glader B, Chew AJ, Tai SJ, Herzog RW, Arruda V, Johnson F, Scallan C, Skarsgard E, Flake AW, High KA: Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat Genet 2000;24:257-261.
24. Grossman Z, Mendelson E, Brok-Simoni F, Mileguir F, Leitner Y, Rechavi G, Ramot B. Detection of adeno-associated virus type 2 in human peripheral blood cells. J Gen Virol 1992;73:961-966.
25. Berns KI, Linden RM. The cryptic life style of adeno-associated virus. Bioessays 1995;17:237-245.
26. Nakai H, Storm TA, Kay MA. Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors. Nat Biotech 2000;18:527-532.
27. Yan Z, Zhang Y, Duan D, Engelhardt JF. Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy. Proc Natl Acad Sci USA 2000;97:6716-6721.
28. Sun L, Li J, Xiao X: Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization. Nat Med 2000;6:599-602.
29. Summerford C, Samulski RJ: Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 1998;72:1438-1445.
30. Qing KY, Mah C, Hansen J, Zhou SZ, Dwarki VJ, Srivastava A: Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat Med 1999;5:71-77.
31. Summerford C, Bartlett JS, Samulski RJ: αVβ5 integrin: a co-receptor for adeno-associated virus 2 infection. Nat Med 1999;5:78-82.
32. Mah C, Qing K, Khuntirat B, Ponnazhagan S, Wang XS, Kube DM, Yoder MC, Srivastava A: Adeno-associated virus type 2-mediated gene transfer: role of epidermal growth factor receptor protein tyrosine kinase in transgene expression. J Virol 1998;72:9835-9843.
33. Qing KY, Wang X-S, Kube DM, Ponnazhagan S, Bajpai A, Srivastava A: Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression. Proc Natl Acad Sci USA 1997;94:10,879-10,884.
34. Halbert CL, Standaert TA, Wilson CB, Miller AD: Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure. J Virol 1998;72:9795-9805.
35. Chirmule N, Xiao W, Truneh A, Schnell MA, Hughes JV, Zoltick P, Wilson JM: Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle. J Virol 2000;74:2420-2425.
36. Xiao X, Li J, Samulski RJ: Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J Virol 1996;70:8098-8108.
37. Fisher KJ, Joos K, Alston J, Yang Y, Haecker SE, High K, Pathak R, Raper SE, Wilson JM: Recombinant adeno-associated virus for muscle directed gene therapy. Nat Med 1997;3:306-312.
38. Duan D, Sharma P, Yang J, Yue Y, Dudus L, Zhang Y, Fisher KJ, Englehardt JF: Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J Virol 1998;72:8568-8577.
39. Kuding TM, Bachman MF, Oehen UW, Hoffmann JJL, Simard CP, Kalberer H, Pircher H, Ohashi PS, Hengartner H, Zinkernagel RM: On the role of antigen in maintaining cytotoxic T-cell memory. Proc Natl Acad Sci USA 1996;93:9716-9723.
40. Erles K, Sebokova P, Schlehofer JR: Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV). J Med Virol 1999;59:406-411.
41. Rudich SM, Zhou S, Srivastava R, Escobedo JA, Perez RV, Manning WC: Dose response to a single intramuscular injection of recombinant adeno-associated virus-erythropoietin in monkeys. J Surg Res 2000;90:102-108.
42. Ge Y, Powell S, Van Roey M, McArthur JG: Factors influencing the development of an anti-factor IX (FIX) immune response following administration of adeno-associated virus-FIX. Blood 2001;97:3733-3737.
43. Liu D-W, Tsao Y.-P, Kung JT, Ding YA, Sytwu H-K, Xiao X, Chen S-L: Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer. J Virol 2000;74:2888-2894.
44. Chao H, Walsh CE: Induction of tolerance to human factor VIII in mice. Blood 2001;97:3311-3312.
45. Xiao W, Chirmule N, Schnell MA, Tazelaar J, Hughes JV, Wilson JM: Route of administration determines induction of T-cell-independent humoral responses to adeno-associated virus vectors. Mol Ther 2000;1:323-329.
46. Beck SE, Jones LA, Chesnut K, Walsh SM, Reynolds TC, Carter BJ, Askin FB, Flotte TR, Guggino WB: Repeated delivery of adeno-associated virus vectors to the rabbit airway. J Virol 1999;73:9446-9455.
47. Manning WC, Paliard X, Zhou S, Bland MP, Lee AY, Hong K, Walker CM, Escobedo JA, Dwarki V: Genetic immunization with adeno-associated virus vectors expressing herpes simplex virus type 2 glycoproteins B and D. J Virol 1997;71:7960-7962.
48. Xin KQ, Urabe M, Yang J, Nomiyama K, Mizukami H, Hamajima K, Nomiyama H, Saito T, Imai M, Monahan J, Okuda K, Ozawa K, Okuda K: A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus. Hum Gene Ther 2001;12:1047-1061.
49. Jooss K, Yang Y, Fisher KJ, Wilson JM. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J Virol 1998;5:4212-4223.
50. Sarukhan A, Soudais C, Danos O, Joos K: Factors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors. J Gene Med 2001;3:260-270.
51. Liu Y, Santin AD, Mane M, Chiriva-Internati M, Parham GP, Ravaggi A, Hermonat PL: Transduction and utility of the granulocyte-macrophage colony-stimulating factor gene into monocytes and dendritic cells by adeno-associated virus. J Interferon Cytokine Res 2000;20:21-30.
52. Ponnazhagan S, Mahendra G, Curiel DT, Shaw DR: Adeno-associated virus type 2-mediated transduction of human monocyte-derived dendritic cells: implications for ex vivo immunotherapy. J Virol 2001;75:9493-9501.
53. Chiriva-Internati M, Liu Y, Salati E, Zhou W, Zhiqing W, Grizzi F, Roman JJ, Lim SH, Hermonat PL: Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells. Eur J Immunol 2002;32:30-38.